NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1417063603 M.D.
Verify on CMS → Raffi Calikyan, M.D.
Pulmonary Disease Physician in Bristol, Rhode Island.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,323 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
6K
Medicare Part D claims · 633 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.5K
116 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Raffi Calikyan, M.D. filed 5,741 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in Bristol, Rhode Island, prescribing 59% generic.
- 6K
- Part D claims, 2023
- 59%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Raffi Calikyan, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
5,741 Top 5% higher than 95% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Raffi Calikyan, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Raffi Calikyan, M.D.?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
5,741 294% vs specialty avg
Specialty distribution in Rhode Island
How Pulmonary Disease Physician compares to other specialties among Rhode Island providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Raffi Calikyan, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 580 METACOM AVE, Bristol, RI, 02809, with a listed phone of (401) 253-0025. NPI 1417063603 was issued on 08/22/2006.
Medicare Part D records for calendar year 2023 show 5,741 prescription claims written by this provider, covering 633 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 41% brand-name and 59% generic by claim count, with an opioid prescribing rate of 1.5%.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,323 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1417063603 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 08/22/2006 |
Hospital and facility affiliations
Facilities where Raffi Calikyan, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Atwood Medical Associates Ltd
Johnston, RI
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Raffi Calikyan, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.5K
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Raffi Calikyan, M.D. - brand share 41.0%
Pulmonary Disease Physician average
41% brand-name claims vs 59% generic, on 5,741 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
5,741
Total Claims
$1.3M
Total Drug Cost
633
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 9,366
- Total Day Supply
- 268,194
- Brand vs Generic
- 41% brand / 59% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $107K
- Opioid Claims
- 85 (1.5% rate)
- Antibiotic Claims
- 177
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.73
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 56, 65-74: 274, 75-84: 219, 85+: 84
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Raffi Calikyan, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
602 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
472 claims
- Breo Ellipta 217
Breo Ellipta
217 claims
- Montelukast Sodium 214
Montelukast Sodium
214 claims
- Prednisone 198
Prednisone
198 claims
- Ventolin Hfa 198
Ventolin Hfa
198 claims
- Fluticasone Propio… 151
Fluticasone Propionate
151 claims
- Anoro Ellipta 150
Anoro Ellipta
150 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 602 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 472 |
| Breo Ellipta Fluticasone/Vilanterol | 217 |
| Montelukast Sodium | 214 |
| Prednisone | 198 |
| Ventolin Hfa Albuterol Sulfate | 198 |
| Fluticasone Propionate | 151 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 150 |
| Atorvastatin Calcium | 137 |
| Furosemide | 137 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Raffi Calikyan, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,323
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider
Raffi Calikyan, M.D.'s 5,741 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Rhode Island
Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Calikyan.
Dr. Jason Aliotta
MD
Providence, RI
Dr. Roger Auth
MD
Riverside, RI
Dr. Bashar Bash
M.D.
Wakefield, RI
Dr. Robert Baute
M.D.
Warwick, RI
Dr. Ghada Bourjeily
MD
Providence, RI
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Rhode Island medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Rhode Island
Frequently Asked Questions
What is Raffi Calikyan, M.D.'s specialty? ▼
Raffi Calikyan, M.D. specializes in Pulmonary Disease Physician and practices in Bristol, Rhode Island. Credentials: M.D..
How much does Raffi Calikyan, M.D. prescribe under Medicare Part D? ▼
In 2023, Raffi Calikyan, M.D. wrote 5,741 Medicare Part D claims totaling $1.3M in drug costs for 633 beneficiaries.
Where is Raffi Calikyan, M.D. located? ▼
Raffi Calikyan, M.D. is located at 580 METACOM AVE, Bristol, RI, 02809. Phone: (401) 253-0025.
What is Raffi Calikyan, M.D.'s NPI number? ▼
Raffi Calikyan, M.D.'s National Provider Identifier (NPI) is 1417063603, issued on 08/22/2006.
Does Raffi Calikyan, M.D. prescribe more brand-name or generic drugs? ▼
Raffi Calikyan, M.D.'s prescribing is 41% brand-name and 59% generic drugs by claim count, with $1.2M in brand drug costs.
Does Raffi Calikyan, M.D. prescribe opioids? ▼
Yes, Raffi Calikyan, M.D. had 85 opioid claims in 2023 with an opioid prescribing rate of 1.5%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,323 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does Raffi Calikyan, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Raffi Calikyan, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Breo Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Raffi Calikyan, M.D. accept Medicare? ▼
Raffi Calikyan, M.D. appears in CMS Medicare data with 5,741 Part D claims and 633 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Raffi Calikyan, M.D.'s credentials? ▼
Raffi Calikyan, M.D.'s NPI is 1417063603 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.